Correlation Between Unicycive Therapeutics and Avenue Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and Avenue Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and Avenue Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unicycive Therapeutics and Avenue Therapeutics, you can compare the effects of market volatilities on Unicycive Therapeutics and Avenue Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of Avenue Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and Avenue Therapeutics.

Diversification Opportunities for Unicycive Therapeutics and Avenue Therapeutics

0.1
  Correlation Coefficient

Average diversification

The 3 months correlation between Unicycive and Avenue is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and Avenue Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avenue Therapeutics and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with Avenue Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avenue Therapeutics has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and Avenue Therapeutics go up and down completely randomly.

Pair Corralation between Unicycive Therapeutics and Avenue Therapeutics

Given the investment horizon of 90 days Unicycive Therapeutics is expected to generate 1.31 times more return on investment than Avenue Therapeutics. However, Unicycive Therapeutics is 1.31 times more volatile than Avenue Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Avenue Therapeutics is currently generating about -0.08 per unit of risk. If you would invest  54.00  in Unicycive Therapeutics on November 5, 2024 and sell it today you would earn a total of  7.00  from holding Unicycive Therapeutics or generate 12.96% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Unicycive Therapeutics  vs.  Avenue Therapeutics

 Performance 
       Timeline  
Unicycive Therapeutics 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Unicycive Therapeutics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak fundamental indicators, Unicycive Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
Avenue Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Avenue Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in March 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Unicycive Therapeutics and Avenue Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Unicycive Therapeutics and Avenue Therapeutics

The main advantage of trading using opposite Unicycive Therapeutics and Avenue Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, Avenue Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avenue Therapeutics will offset losses from the drop in Avenue Therapeutics' long position.
The idea behind Unicycive Therapeutics and Avenue Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Commodity Directory
Find actively traded commodities issued by global exchanges
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios